UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: B | C | E | F | G | H | I | K | L | O | P | T | U
Number of items: 21.


Behranwala, KA; Chettiar, K; El-Bahrawy, M; Stamp, G; Kakkar, AK; (2005) Retroperitoneal myolipoma. World J Surg Oncol , 3 72 - ?. 10.1186/1477-7819-3-72.


Cohen, AT; Kakkar, AK; (2005) Venous thromboembolic disease in cancer patients in Europe - an opportunity for improved prevention: the VITAE Thrombosis Study. EJC SUPPL , 3 (2) 156 - 156.


Eriksson, BI; Borris, L; Dahl, OE; Haas, S; Huisman, MV; Kakkar, AK; ... Kalebo, P; + view all (2005) Prevention of venous thromboembolism after total hip replacement with once-daily BAY 59-7939 - An oral, direct factor Xa inhibitor. In: BLOOD. (pp. 86A - 86A). AMER SOC HEMATOLOGY


Fegan, PG; Shore, AC; Mawson, D; Tooke, JE; MacLeod, KM; (2005) Microvascular endothelial function in subjects with Type 2 diabetes and the effect of lipid-lowering therapy. DIABETIC MED , 22 (12) 1670 - 1676. 10.1111/j.1464-5491.2005.01719.x.


Gooding, KM; MacLeod, KM; Spyer, G; Ewings, P; Tooke, JE; Shore, AC; (2005) Impact of hormone replacement therapy on microvascular function in healthy and Type 2 diabetic postmenopausal women. DIABETIC MED , 22 (5) 536 - 542.


Haas, S; Wolf, H; Kakkar, AK; Fareed, J; Encke, A; (2005) Prevention of fatal pulmonary embolism and mortality in surgical patients - A randomized double-blind comparison of LMWH with unfractionated heparin. THROMB HAEMOSTASIS , 94 (4) 814 - 819. 10.1160/TH02-10-0189.


Issa, R.; (2005) Genomic variation and gene expression of clinical isolates of Mycobacterium tuberculosis. Doctoral thesis, University of London. Green open access


Kakkar, AK; (2005) Low-molecular-weight heparin and survival in patients with malignant disease. Cancer Control , 12 Suppl 1 22 - 30. Gold open access

Kakkar, AK; (2005) Thromboprophylaxis in the cancer patient. In: Shirato, K, (ed.) VENOUS THROMBOEMBOLISM: PREVENTION AND TREATMENT. (pp. 151 - 157). SPRINGER-VERLAG TOKYO

Kakkar, AK; Haas, S; Wolf, H; Encke, A; (2005) Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients - The MC-4 cancer substudy. THROMB HAEMOSTASIS , 94 (4) 867 - 871. 10.1160/TH04-03-0189.

Konopatskaya, O; Shore, AC; Tooke, JE; Whatmore, JL; (2005) A role for heterotrimeric GTP-binding proteins and ERK1/2 in insulin-mediated, nitric-oxide-dependent, cyclic GMP production in human umbilical vein endothelial cells. DIABETOLOGIA , 48 (3) 595 - 604. 10.1007/s00125-004-1653-7.


Lee, AYY; Rickles, FR; Julian, JA; Gent, M; Baker, RI; Bowden, C; ... Levine, MN; + view all (2005) Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. JOURNAL OF CLINICAL ONCOLOGY , 23 (10) 2123 - 2129. 10.1200/JCO.2005.03.133.

Levine, M; Kakkar, AK; (2005) Catheter-associated thrombosis: Thromboprophylaxis or not? J CLIN ONCOL , 23 (18) 4006 - 4008. 10.1200/JCO.2005.12.901.

Levine, MN; Lee, AYY; Kakkar, AK; (2005) Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality? Reply. J CLIN ONCOL , 23 (28) 7250 - 7250. 10.1200/JCO.2005.02.1527.


Ockrim, JL; Lalani, EN; Kakkar, AK; Abel, PD; (2005) Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism. J UROLOGY , 174 (2) 527 - 532. 10.1097/01.ju.0000165567.99142.1f.


Petralia, GA; Lemoine, NR; Kakkar, AK; (2005) Mechanisms of disease: the impact of antithrombotic therapy in cancer patients. NAT CLIN PRACT ONCOL , 2 (7) 356 - 363. 10.1038/ncponc0225.

Piovella, F; Anderson, FA; Decousus, H; FitzGerald, G; Bergmann, JF; Kakkar, AK; ... IMPROVE Investigators,; + view all (2005) Rates of clinically apparent venous thromboembolism and death resulting from pulmonary embolism among unselected hospitalized acutely ill medical patients versus rates predicted from clinical studies. In: BLOOD. (pp. 463A - 463A). AMER SOC HEMATOLOGY


Tooke, JE; Gooding, KM; Elston, LM; Sriraman, R; Urquhart, R; Shore, AC; (2005) Effect of pioglitazone on microcirculation parameters in patients with type 2 diabetes treated with insulin. In: DIABETES. (pp. A142 - A142). AMER DIABETES ASSOC

Turpie, AGG; Bauer, KA; Borris, L; Dahl, OE; Fisher, WD; Gent, M; ... Eriksson, BI; + view all (2005) Thromboprophylaxis after orthopaedic surgery with an oral, direct factor Xa inhibitor: Pooled results of two phase Iib clinical trials. In: BLOOD. (pp. 85A - 85A). AMER SOC HEMATOLOGY


Urquhart, R; Elston, LM; Gooding, KM; Sriraman, R; Shore, AC; Tooke, JE; (2005) The effect of pioglitazone on inflammatory markers in patients with type 2 diabetes treated with insulin. In: DIABETES. (pp. A517 - A517). AMER DIABETES ASSOC

Urquhart, R; Gooding, KM; Elston, LM; Sriraman, R; Shore, AC; Tooke, JE; (2005) Effect of pioglitazone on microcirculation parameters in patients with type 2 diabetes treated with insulin. In: DIABETOLOGIA. (pp. A282 - A282). SPRINGER

This list was generated on Sun May 24 01:39:57 2015 BST.